Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01220414 · ClinicalTrials.gov registry record · NA
Attenuation of Pain in Men and Women
A NA study of Pain, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT01220414 is a NA study of Pain that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 60 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01220414, a NA study of Pain, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine opioid and endocannabinoid mechanisms of exercise-induced analgesia in men and women.
Conditions Studied
Interventions
- DRUG Naltrexone, then placebo
- DRUG Placebo, then Naltrexone
Study Locations (1)
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01220414
The ClinicalTrials.gov registry entry for NCT01220414 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Naltrexone, then placebo is the first listed.
NCT01220414 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01220414 about?
NCT01220414 is a clinical study titled "Attenuation of Pain in Men and Women". The purpose of this study is to examine opioid and endocannabinoid mechanisms of exercise-induced analgesia in men and women.
What is the current status of trial NCT01220414?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2010-09. Estimated completion is 2013-01.
What conditions does trial NCT01220414 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT01220414?
The interventions under investigation include: Naltrexone, then placebo (DRUG), Placebo, then Naltrexone (DRUG).
Who is sponsoring clinical trial NCT01220414?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01220414 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.